Sell-Side Researchers Offering Their Take on Cimarex Energy Co (NYSE:XEC), Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)

According to data provided by Zacks Research, Cimarex Energy Co (NYSE:XEC) has a consensus target price of $155.892 on the stock. Out of the polled analysts providing targets, the high is currently $206, while the low is resting at $112. Analyst price targets may vary depending on the individual method used to calculate the estimate.
Turning to earnings, analysts are expecting Cimarex Energy Co (NYSE:XEC) to post a current quarter EPS of $0.84. This consensus number is compiled by Zacks Research. For the period ending on 2016-12-31, the company reported EPS for the quarter of $0.6. The resulting surprise factor from the difference between the reported number and the consensus estimate going into earnings was 1.69%. After a company reports earnings, the stock may see increased activity. The next earnings report date is scheduled on or near 2017-05-08.
In terms of analyst ratings, Cimarex Energy Co (NYSE:XEC) has a current ABR of 1.92. This average broker recommendation is given by Zacks using a scale from 1 to 5. According to this scale, a rating of 1 or 2 would indicate a Buy, and a rating of 4 or 5 would signify a Sell recommendation. A 3 would indicate a Hold on the stock.

In the most recent session, Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) shares have traded -0.289%. Following the stock price relative to moving averages may offer enhanced perspective on stock performance. After a recent review, the stock has been noted $-0.072 away from the 50-day moving average of $12.167 and $0.485 away from the 200-day moving average of $11.610. From a different angle, the stock has been recently recorded -20.270% off of the 52-week high of 15.170 and +23.418% removed from the 52-week low of 9.800. 

Currently, Allscripts Healthcare Solutions has a price to earnings ratio of N/A. Analysts and investors may also opt to evaluate a company's PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. If a company has a PEG Ratio below one, it may be viewed as undervalued. If a company has a PEG Ratio above one, it may show that the company is overvalued. A PEG Ratio near one may be viewed as fair value. The stock currently has a PEG Ratio of 1.180.

Price Target Update

Analysts polled by Thomson Reuters have set a consensus target price of $14.240 on shares. Target prices may vary from one analyst to another due to the various ways they may proceed to calculate future price targets. This is a near-term estimation for the next 12-18 months.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Comment